News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Exiqon A/S Launches LNA™ Microrna Mimics With No Off-Target Effect



4/23/2014 9:25:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Exiqon A/S (NASDAQ OMX Copenhagen), a leading supplier of high-value gene expression analysis products, today announced the launch of highly potent miRCURY LNA™ microRNA Mimics for functional analysis.

The new miRCURY LNA™ microRNA Mimics enable sub-nanomolar potency and allow scientists to conduct high quality dose-response experiments for instance by resembling disease situations.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES